E-MEXP-13 - Transcription profiling of human VHL treated A498 renal cancer cells

Status
Released on 18 September 2003, last updated on 27 March 2012
Organism
Homo sapiens
Samples (6)
Array (1)
Protocols (4)
Description
A498 cells, established from a clear cell renal cell cancer of a 52 years old male patient, were obtained from ATCC and maintained in DMEM supplemented with 10% fetal calf serum (FCS). This cell line does not express functional VHL. A498 subclones stably transfected with HA-pVHL30 or control plasmid have been described and were maintained in 0.5 mg/ml G418.
Experiment types
transcription profiling by array, transcript identification
Contacts
Edward J Oakeley <oakeley@fmi.ch>, Holger Moch, Jitka Sulitkova, Joanna Lisztwan, Peter Staller, Wilhelm Krek
Citation
The von Hippel-Lindau tumour suppressor protein pVHL negatively regulates CXCR4 chemokine receptor expression. Edward Oakeley,Wilhelm Krek,Peter Staller,Jitka Sulitkova,Joanna Lisztwan,Holger Moch.
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-MEXP-13.idf.txt
Sample and data relationshipE-MEXP-13.sdrf.txt
Raw data (1)E-MEXP-13.raw.1.zip
Array designA-AFFY-1.adf.txt
R ExpressionSetE-MEXP-13.eSet.r
Links